NCT01090596View on ClinicalTrials.gov

Changes in mRNA Expression Following Exposure to Naproxen

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Healthy
Interventions
DRUG

Naproxen

500mg naproxen, twice daily for 7 days

DRUG

Placebo

1 tab,twice a day for a seven days

All Listed Sponsors
lead

Research Associates of New York, LLP

OTHER

NCT01090596 - Changes in mRNA Expression Following Exposure to Naproxen | Biotech Hunter | Biotech Hunter